SCHEMBL16596339

SCHEMBL16596339

O=S(=O)(Oc1ccc(N(c2ccc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)c2ccc(-c3cccc4c3oc3ccccc34)cc2)cc1)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.35
▸ PRKDC P78527 3/20 0.34
▸ CDC14B O60729 2/20 0.32
▸ CDC14A Q9UNH5 2/20 0.32
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ GGPS1 O95749 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.31
▸ PPARG P37231 4/20 0.31
▸ PPARA Q07869 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ NR2E3 Q9Y5X4 1/20 0.31
▸ NCOR2 Q9Y618 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12037405 0.96 ALOX5 (0.35) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL16596327 0.94 ALOX5 (0.35) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL16596207 0.91 ALOX5 (0.42) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL16596312 0.90 ALOX5 (0.43) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL10306932 0.86 ALOX5 (0.44) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL21971315 0.86 ALOX5 (0.44) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL10306817 0.86 ALOX5 (0.44) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL10306880 0.86 ALOX5 (0.44) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL10306921 0.86 ALOX5 (0.44) ALOX5PRKDCCDC14BCDC14APTGES2
SCHEMBL10306913 0.86 ALOX5 (0.44) ALOX5PRKDCCDC14BCDC14APTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9425402-B2 Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer IDEMITSU KOSAN CO., LTD. (JP) 2016-08-23 — — US disclosed
US-20150084031-A1 NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER IDEMITSU KOSAN CO (JP) 2015-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150084031-A1 NOVEL POLYMERIZABLE MONOMER, AND MATERIAL FOR ORGANIC DEVICE, HOLE INJECTION/TRANSPORT MATERIAL, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EACH COMPRISING POLYMER (POLYMERIC COMPOUND) OF THE POLYMERIZABLE MONOMER EPB41, USE1, EPB41L2 ALOX5 919/4885PRKDC 4823/4885CDC14B 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback